ALPHA TEKNOVA, INC. Lease, Cost
ALPHA TEKNOVA, INC. (TKNO) reported Lease, Cost of $781.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-06
- ALPHA TEKNOVA, INC. lease, cost for the quarter ending 2026-06-30 was $781.00K, a 2.01% decline year-over-year.
- ALPHA TEKNOVA, INC. lease, cost for the quarter ending 2026-03-31 was $781.00K, a 2.01% decline year-over-year.
- ALPHA TEKNOVA, INC. lease, cost for the quarter ending 2025-12-31 was $795.00K, a 6.80% decline year-over-year.
- ALPHA TEKNOVA, INC. lease, cost for the quarter ending 2025-09-30 was $798.00K, a 6.56% decline year-over-year.
- ALPHA TEKNOVA, INC. lease, cost for fiscal 2025 was $3.19M, a 6.65% decline from fiscal 2024.
- ALPHA TEKNOVA, INC. lease, cost for fiscal 2024 was $3.42M, a 17.88% increase from fiscal 2023.
- ALPHA TEKNOVA, INC. lease, cost for fiscal 2023 was $2.90M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $781.00K 10-Q · filed 2026-08-06 | $1.56M 10-Q · filed 2026-08-06 | $2.36M derived: sum of 3 quarters · filed 2026-08-06 | $3.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $781.00K 10-Q · filed 2026-05-07 | $1.58M derived: sum of 2 quarters · filed 2026-05-07 | $2.37M derived: sum of 3 quarters · filed 2026-05-07 | $3.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.59M derived: sum of 2 quarters · filed 2026-03-02 | $2.39M derived: sum of 3 quarters · filed 2026-08-06 | $3.19M 10-K · filed 2026-03-02 |
| 2025-09-30 | $798.00K 10-Q · filed 2025-11-07 | $1.59M derived: sum of 2 quarters · filed 2026-08-06 | $2.39M 10-Q · filed 2025-11-07 | $3.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $797.00K 10-Q · filed 2026-08-06 | $1.60M 10-Q · filed 2026-08-06 | $2.45M derived: sum of 3 quarters · filed 2026-08-06 | $3.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $797.00K 10-Q · filed 2026-05-07 | $1.65M derived: sum of 2 quarters · filed 2026-05-07 | $2.50M derived: sum of 3 quarters · filed 2026-05-07 | $3.36M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $853.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.71M derived: sum of 2 quarters · filed 2026-03-02 | $2.56M derived: sum of 3 quarters · filed 2026-03-02 | $3.42M 10-K · filed 2026-03-02 |
| 2024-09-30 | $854.00K 10-Q · filed 2025-11-07 | $1.71M derived: sum of 2 quarters · filed 2025-11-07 | $2.56M 10-Q · filed 2025-11-07 | $3.25M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $854.00K 10-Q · filed 2025-08-08 | $1.71M 10-Q · filed 2025-08-08 | $2.40M derived: sum of 3 quarters · filed 2025-08-08 | $3.09M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $854.00K 10-Q · filed 2025-05-09 | $1.55M derived: sum of 2 quarters · filed 2025-05-09 | $2.24M derived: sum of 3 quarters · filed 2025-05-09 | $2.94M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $692.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.39M derived: sum of 2 quarters · filed 2025-03-07 | $2.08M derived: sum of 3 quarters · filed 2025-03-07 | $2.90M 10-K · filed 2025-03-07 |
| 2023-09-30 | $694.00K 10-Q · filed 2024-11-08 | $1.39M derived: sum of 2 quarters · filed 2024-11-08 | $2.21M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $695.00K 10-Q · filed 2024-08-13 | $1.51M 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $816.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |